{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:27Z","timestamp":1790109807131,"version":"4.0.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The purpose of this review is to discuss recent observations of epigenetic changes related to the complex pathogenesis of systemic vasculitides and their contribution to the field.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>There have been new observations of epigenetic changes in vasculitis and their potential role in disease pathogenesis in antineutrophil cytoplasmic antibody-associated vasculitis, giant-cell arteritis, Kawasaki disease, Beh\u00e7et's disease, and IgA vasculitis. Some of this recent work has focused on the efficacy of using DNA methylation and miRNA expression as clinical biomarkers for disease activity and how DNA methylation and histone modifications interact to regulate disease-related gene expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>DNA methylation, histone modification, and miRNA expression changes are all fruitful ground for biomarker discovery and therapeutic targets in vasculitis. Current knowledge has provided targeted and suggested effects, but in many cases, has relied upon small cohorts, cosmopolitan cell populations, and limited knowledge of functional interactions. Expanding our knowledge of how these epigenetic mechanisms interact in a disease-specific and cell-specific manner will help to better understand the pathogenesis of systemic vasculitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000451","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T23:56:36Z","timestamp":1506642996000},"page":"4-15","source":"Crossref","is-referenced-by-count":24,"title":["An update on the role of epigenetics in systemic vasculitis"],"prefix":"10.1097","volume":"30","author":[{"given":"Patrick","family":"Coit","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Faculty of Medicine, Marmara University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Sawalha","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10157-013-0830-8","article-title":"Epidemiology and clinical features of systemic vasculitis","volume":"17","author":"Scott","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/BOR.0000000000000124","article-title":"Genetics of vasculitis","volume":"27","author":"Carmona","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rheumatology\/keg116","article-title":"Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment","volume":"42","author":"Nordborg","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20230829","first-page":"S27","article-title":"The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet's disease","volume":"25","author":"Mumcu","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R7-20230829","first-page":"25","article-title":"Gene-environment interactions and epigenetic basis of human diseases","volume":"10","author":"Liu","year":"2008","journal-title":"Curr Issues Mol Biol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tibs.2014.05.002","article-title":"New concepts in DNA methylation","volume":"39","author":"Jeltsch","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/71750","article-title":"DNA methyltransferase Dnmt1 associates with histone deacetylase activity","volume":"24","author":"Fuks","year":"2000","journal-title":"Nat Genet"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Noncoding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1742-4658.2011.08089.x","article-title":"MicroRNAs and epigenetics","volume":"278","author":"Sato","year":"2011","journal-title":"FEBS J"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1681\/ASN.2014090903","article-title":"Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cei.12301","article-title":"Neutrophils from vasculitis patients exhibit an increased propensity for activation by antineutrophil cytoplasmic antibodies","volume":"176","author":"Ohlsson","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/jlb.66.6.989","article-title":"The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules","volume":"66","author":"Cowland","year":"1999","journal-title":"J Leukoc Biol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/01.ASN.0000135058.46193.72","article-title":"Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"15","author":"Yang","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta","year":"2010","journal-title":"J Clin Invest"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1681\/ASN.2016050548","article-title":"Gene-specific DNA methylation changes predict remission in patients with ANCA-associated vasculitis","volume":"28","author":"Jones","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13148-016-0251-0","article-title":"Histone modification signature at myeloperoxidase and proteinase 3 in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"8","author":"Yang","year":"2016","journal-title":"Clin Epigenetics"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2015.10.002","article-title":"Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis","volume":"67","author":"Sawalha","year":"2016","journal-title":"J Autoimmun"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/ndt\/gfp783","article-title":"Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis","volume":"25","author":"Nogueira","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cell.2012.09.002","article-title":"Asymmetrically modified nucleosomes","volume":"151","author":"Voigt","year":"2012","journal-title":"Cell"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3899\/jrheum.140318","article-title":"Projected worldwide disease burden from giant cell arteritis by 2050","volume":"42","author":"De Smit","year":"2015","journal-title":"J Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1196\/annals.1358.023","article-title":"Vascular dendritic cells in giant cell arteritis","volume":"1062","author":"Weyand","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.34327","article-title":"Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis","volume":"64","author":"Terrier","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/annrheumdis-2014-207116","article-title":"DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis","volume":"75","author":"Coit","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/art.30353","article-title":"Calcium signaling in systemic lupus erythematosus T cells: a treatment target","volume":"63","author":"Kyttaris","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bone.2009.05.009","article-title":"NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation","volume":"45","author":"Choo","year":"2009","journal-title":"Bone"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1136\/annrheumdis-2015-207846","article-title":"MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis","volume":"75","author":"Croci","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"e000745","DOI":"10.1161\/JAHA.112.000745","article-title":"Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm","volume":"1","author":"Kin","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/ar3358","article-title":"Giant cell arteritis: immune and vascular aging as disease risk factors","volume":"13","author":"Mohan","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08916930802024889","article-title":"Epigenetics aging, and autoimmunity","volume":"41","author":"Yung","year":"2008","journal-title":"Autoimmunity"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/epi-2016-0143","article-title":"Age-associated DNA methylation changes in naive CD4+ T cells suggest an evolving autoimmune epigenotype in aging T cells","volume":"9","author":"Dozmorov","year":"2017","journal-title":"Epigenomics"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.arr.2013.05.001","article-title":"MicroRNAs linking inflamm-aging, cellular senescence and cancer","volume":"12","author":"Olivieri","year":"2013","journal-title":"Ageing Res Rev"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"b1514","DOI":"10.1136\/bmj.b1514","article-title":"Kawasaki disease","volume":"338","author":"Harnden","year":"2009","journal-title":"BMJ"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"e103329","DOI":"10.1371\/journal.pone.0103329","article-title":"A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis","volume":"9","author":"Duan","year":"2014","journal-title":"PLoS One"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/art.38976","article-title":"Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"(Suppl 1)","key":"R43-20230829","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12920-016-0197-2","article-title":"Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease","volume":"9","author":"Li","year":"2016","journal-title":"BMC Med Genomics"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","article-title":"Masquerader: high mobility group box-1 and cancer","volume":"13","author":"Ellerman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imbio.2014.07.016","article-title":"FcgammaRIIa cross-talk with TLRs, IL-1R, and IFNgammaR selectively modulates cytokine production in human myeloid cells","volume":"220","author":"Vogelpoel","year":"2015","journal-title":"Immunobiology"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.18632\/oncotarget.14497","article-title":"Identifying genetic hypomethylation and upregulation of toll-like receptors in Kawasaki disease","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","article-title":"The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease","volume":"162","author":"Jia","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/cei.12418","article-title":"Regulatory T cell microRNA expression changes in children with acute Kawasaki disease","volume":"178","author":"Ni","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"e58159","DOI":"10.1371\/journal.pone.0058159","article-title":"Differential expression of miR-145 in children with Kawasaki disease","volume":"8","author":"Shimizu","year":"2013","journal-title":"PLoS One"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: cell-cell communication function?","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front Genet"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12915-016-0268-z","article-title":"Q&A: What are exosomes, exactly?","volume":"14","author":"Edgar","year":"2016","journal-title":"BMC Biol"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00246-013-0846-6","article-title":"Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease","volume":"35","author":"Yun","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"R53-20230829","first-page":"8257862","article-title":"Serum miR-200c and miR-371-5p as the useful diagnostic biomarkers and therapeutic targets in Kawasaki disease","volume":"2017","author":"Zhang","year":"2017","journal-title":"Biomed Res Int"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"e0175407","DOI":"10.1371\/journal.pone.0175407","article-title":"A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"44706","DOI":"10.1038\/srep44706","article-title":"Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease","volume":"7","author":"Jia","year":"2017","journal-title":"Sci Rep"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"pii: e004878","DOI":"10.1161\/JAHA.116.004878","article-title":"Bone marrow-derived MicroRNA-223 works as an endocrine genetic signal in vascular endothelial cells and participates in vascular injury from Kawasaki disease","volume":"6","author":"Chu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jaci.2016.04.050","article-title":"Next-generation sequencing identifies micro-RNA-based biomarker panel for Kawasaki disease","volume":"138","author":"Kuo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/pr.2016.93","article-title":"MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease","volume":"80","author":"Saito","year":"2016","journal-title":"Pediatr Res"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","article-title":"Behcet's disease physiopathology: a contemporary review","volume":"7","author":"Zeidan","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","article-title":"Pathogenesis of Behcet's disease: autoinflammatory features and beyond","volume":"37","author":"Gul","year":"2015","journal-title":"Semin Immunopathol"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","article-title":"The immunogenetics of Behcet's disease: a comprehensive review","volume":"64","author":"Takeuchi","year":"2015","journal-title":"J Autoimmun"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat Genet"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease","volume":"128","author":"Geri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R65-20230829","first-page":"S16","article-title":"Imbalance of Th17 to Th1 cells in Behcet's disease","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/08820139.2017.1306865","article-title":"Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet's disease","volume":"46","author":"Deniz","year":"2017","journal-title":"Immunol Invest"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.38409","article-title":"Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behcet's disease","volume":"66","author":"Hughes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/rheumatology\/ket438","article-title":"Increased Notch pathway activation in Behcet's disease","volume":"53","author":"Qi","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fgene.2015.00186","article-title":"Genetic variants in microRNA genes: impact on microRNA expression, function, and disease","volume":"6","author":"Cammaerts","year":"2015","journal-title":"Front Genet"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/annrheumdis-2012-201627","article-title":"MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome","volume":"73","author":"Zhou","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00439-013-1346-8","article-title":"A functional variant of premiRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis","volume":"132","author":"Qi","year":"2013","journal-title":"Human Genetics"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/BOR.0b013e32835d8e2a","article-title":"Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge","volume":"25","author":"Piram","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clim.2012.12.009","article-title":"Aberrant histone modifications in peripheral blood mononuclear cells from patients with Henoch-Schonlein purpura","volume":"146","author":"Luo","year":"2013","journal-title":"Clin Immunol"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1128\/MCB.00311-06","article-title":"Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression","volume":"26","author":"Yan","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ni1424","article-title":"Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells","volume":"8","author":"Djuretic","year":"2007","journal-title":"Nat Immunol"},{"key":"R76-20230829","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1167\/iovs.12-9832","article-title":"Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome","volume":"53","author":"Zhou","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R77-20230829","first-page":"S56","article-title":"MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behcet's disease","volume":"34","author":"Na","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R78-20230829","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12950-016-0130-7","article-title":"MicroRNAs differentially expressed in Behcet disease are involved in interleukin-6 production","volume":"13","author":"Woo","year":"2016","journal-title":"J Inflamm (Lond)"},{"key":"R79-20230829","first-page":"S72","article-title":"Global microRNA profiling of peripheral blood mononuclear cells in patients with Behcet's disease","volume":"33","author":"Erre","year":"2015","journal-title":"Clin Exp Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201801000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:00:51Z","timestamp":1693292451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201801000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000451","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}